Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023

Stock Price vs Company Growth
1d
5.7%
1w
6.3%
1m
7.5%
3m
8.6%
6m
7.4%
1y
25.1%
all
18.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 656 5.7%
584
818
Company Overview

Sales
1,819 Cr
Growth: -9.9%
Profit after Tax
187 Cr
Growth: -12.7%
Small Cap
5,950 Cr
P/E: 31.9x
Industry P/E: 31.1x
Fundamentals

Sales (Cr) ₹ 1,819
Growth -9.9%
EBITDA 21.2%
P/S 3.3x
Dividend 0.5%
P/E 31.9x
Book Value ₹ 234
PEG Ratio -3.2x
ROE 8.9%
P/B 2.8x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Investors (14)
Followers (1)